RxDoctor Payments Data

My Nguyen, MD

Radiation Oncology · Nashville, TNNPI 1043326127

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Boston Scientific at 33.9% of the total. 2025 is the largest year on record at $597, more than ten times the $32 reported in 2020.

$1,885in general payments, 2019–2025

Across 29 payments — averaging $64.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$639
  • AstraZeneca$317
  • Bioprotect Medical, Inc.$257
  • Novocure Inc.$160
  • GT Medical Technologies, Inc$155
  • Palette Life Sciences, Inc.$136
  • plus $221 from 6 others

What the payments were for

  • Food & beverage$1,885100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,885 in reported general payments places this provider in the 70th percentile of 115 radiation oncology providers in Tennessee.

See all radiation oncology providers in Tennessee

Medicare billing

Part B allowed, 2024
$129,769
Medicare patients
173
Services billed
1,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate19$2,474
Tamsulosin Hcl145$1,932
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$908
Dexamethasone17$672
Oxybutynin Chloride24$408
Ciprofloxacin Hcl60$290
Memantine Hcl15$218
Levothyroxine Sodium39$199

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →